Hypericum perforatum with Vitex agnus-castus in menopausal symptoms: A randomized, controlled trial

Menopause

Volumn 16, Issue 1, 2009, Pages 156-163

  Van Die, M Diana ^a   Burger, Henry G ^b   Bone, Kerry M ^c,d   Cohen, Marc M ^a   Teede, Helena J ^e  

^a RMIT UNIVERSITY   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c MediHerb   (Australia)

^d UNIVERSITY OF NEW ENGLAND   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

Complementary medicine; Depression; Hot flushes; Hypericum perforatum; Menopause; Vitex agnus castus

Indexed keywords

HYPERICUM PERFORATUM EXTRACT; PLACEBO; VITEX AGNUS CASTUS EXTRACT; PLANT EXTRACT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MORNING DOSAGE; PATIENT COMPLIANCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; ANXIETY; CHEMISTRY; HYPERICUM; MENOPAUSE; MIDDLE AGED; PHYSIOLOGY; PHYTOTHERAPY; VITEX;

ANXIETY; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HOT FLASHES; HUMANS; HYPERICUM; MENOPAUSE; MIDDLE AGED; PHYTOTHERAPY; PLACEBOS; PLANT EXTRACTS; QUALITY OF LIFE; VITEX;

EID: 64049104890     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e31817fa9e0     Document Type: Article

References (39)

1. Johnson KC, Morely-Kotchen J, Ockene J. Investigators: Working Group for the Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
2. Lawton B, Rose S, McLeod D, Dowell A. Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users. BMJ 2003;327:845-846.
3. Van der Sluijs CP, Bensoussan A, Liyanage L, Shah S. Women's health during mid-life survey: the use of complementary and alternative medicine by symptomatic women transitioning through menopause in Sydney. Menopause 2007;14:397-403.
4. Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 2006;166:1453-1465.
5. Bodinet C, Freudenstein J. Influence of marketed herbal menopause preparations on MCF-7 cell proliferation. Menopause 2004;11:281-289.
6. Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil Steril 2004;82:145-148.
7. British Herbal Medicine Association. British Herbal Pharmacopoeia. Bournemouth, UK: British Herbal Medicine Association, 1983.
8. Christie S, Walker AF. Vitex agnus-castus L.: (1) A review of its traditional and modern therapeutic use; (2) current use from a survey of practitioners. Eur J Herbal Med 1997;3:29-45.
9. Butterweck V. Mechanism of action of St. John's wort in depression: what is known? CNS Drugs 2003;17:539-562.
10. Chen F, Rezvani AH, Lawrence AJ. Autoradiographic quantification of neurochemical markers of serotonin, dopamine and opioid systems in rat brain mesolimbic regions following chronic St. John's wort treatment. Naunyn Schmiedebergs Arch Pharmacol 2003;367:126-133.
11. Jarry H, Leonhardt S, Gorkow C, Wuttke W. In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Exp Clin Endocrinol 1994;102:448-454.
12. Webster DE, Lu J, Chen SN, Farnsworth NR, Wang ZJ. Activation of the mu-opiate receptor by Vitex agnus-castus methanol extracts: implication for its use in PMS. J Ethnopharmacol 2006;106:216-221.
13. Nelson HD, Vesco KK, Haney E, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006;295:2057-2071.
14. Freedman R. Physiology of hot flushes. Am J Hum Biol 2001;13:453-464.
15. Dericks-Tan JS, Schwinn P, Hildt C. Dose-dependent stimulation of melatonin secretion after administration of agnus-castus. Exp Clin Endocrinol Diabetes 2003;111:44-46.
16. Meier B, Berger D, Hoberg E, Sticher O, Schaffner W. Pharmacological activities of Vitex agnus-castus extracts in vitro. Phytomedicine 2000;7:373-381.
17. Linde K, Mulrow CD, Berner M, Egger M. St. John's wort for depression. Cochrane Database Syst Rev 2005(2):CD000448.
18. Grube B, Walper A, Wheatley MD. St. John's wort extract: efficacy for menopausal symptoms of psychological origin. Adv Ther 1999;16:177-186.
19. Uebelhack R, Blohmer JU, Graubaum HJ, Busch R, Gruenwald J, Wernecke KD. Black cohosh and St. John's wort for climacteric complaints: a randomized trial. Obstet Gynecol 2006;107:247-255.
20. Briese V, Stammwitz U, Friede M, Henneicke-von Zepelin HH. Black cohosh with or without St. John's wort for symptom-specific climacteric treatment-results of a large-scale, controlled, observational study. Maturitas 2007;57:405-414.
21. Boblitz N, Schrader E, Henneicke-von-Zepelin HH, Wüstenberg P. Benefit of a fixed drug combination containing St. John's wort and black cohosh for climacteric patients - results of a randomised clinical trial. Focus Altern Complement Ther 2000;51:83-107.
22. Chung DJ, Kim HY, Park KH, et al. Black cohosh and St. John's wort (GYNO-Plus) for climacteric symptoms. Yonsei Med J 2007;48:289-294.
23. Rotem C, Kaplan B. Phyto-Female Complex for the relief of hot flushes, night sweats and quality of sleep: randomized, controlled, double-blind pilot study. Gynecol Endocrinol 2007;23:117-122.
24. Schellenberg R. Treatment for the premenstrual syndrome with Agnus castus fruit extract: prospective, randomised placebo controlled trial. BMJ 2001;322:134-137.
25. Garamaszegi C, Dennerstein L, Dudley E, Guthrie JR, Ryan M, Burger H. Menopausal status; subjectively and objectively defined. J Psychosom Obstet Gynecol 1998;19:165-173.
26. Greene JG. Guide to the Greene Climacteric Scale. Glasgow: University of Glasgow, 1991.
27. Vorbach EU, Hübner WD, Arnoldt KH. Effectiveness and tolerance of the Hypericum extract LI 160 in comparison with imipramine. Randomized double blind study with 209 patients with diagnosis of recurrent severe major depressive disorders. Nervenheilkunde 1993;12:290-296.
28. Bærug U, Winge T, Nordland G, et al. Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms? Climacteric 1998;1:219-228.
29. Liggins J, Grimwood R, Bingham SA. Extraction and quantification of lignan phytoestrogens in food and human samples. Anal Biochem 2000;287:102-109.
30. King RA, Bignell C. Concentrations of isoflavone phytoestrogens and their glucosides in Australian soya beans and soya foods. Aust J Nutr Diet 2000;57:70-78.
31. Davis S, Briganti E, Chen R, Dalais FS, Bailey M, Burger H. The effects of Chinese medicinal herbs on postmenopausal vasomotor symptoms of Australian women. Med J Aust 2001;174:68-71.
32. Hirata JD, Swiersz LM, Zell B, Small R, Ettinger MD. Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril 1997;68:981-986.
33. Baber RJ, Templeman C, Morton T, Kelly GE, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999;2:85-92.
34. Kalb R, Trautmann-Sponsel RD, Keiser M. Efficacy and tolerability of Hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomised double-blind multicentre clinical trial. Pharmacopsychiatry 2001;34:96-103.
35. MacLennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2004(4):CD002978.
36. Davidson RT. Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St. John's wort) in major depressive disorder: a randomized controlled trial. JAMA 2002;287:1807-1814.
37. Rubinow DR, Roca CA, Schmidt PJ. Estrogens and depression in women. In: Lobo R, ed. Treatment of the Postmenopausal Woman. Basic and Clinical Aspects, 3rd ed. Burlington, MA: Academic Press, 2007:307-322.
38. Koshi EB, Short CA. Placebo theory and its implications for research and clinical practice: a review of the recent literature. Pain Pract 2007;7:4-20.
39. Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA 1998;280:1585-1589.